SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Cashflow Statement
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Cash Flow from Financing Activities | ₹199 Cr | ₹42 Cr | ₹617 Cr |
What is the latest Cash Flow from Financing Activities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹199 Cr |
| Mar2024 | ₹42 Cr |
| Mar2023 | ₹617 Cr |
How is Cash Flow from Financing Activities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹199 Cr | 369.89 | |
| Mar2024 | ₹42 Cr | -93.12 | |
| Mar2023 | ₹617 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹4,814.0 Cr | 3.7% | 12.6% | -5.3% | Stock Analytics | |
| SAGILITY INDIA | ₹19,432.2 Cr | -1.5% | 4.1% | -2.1% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹17,409.0 Cr | 0.9% | 3.1% | -32.7% | Stock Analytics | |
| LATENT VIEW ANALYTICS | ₹6,121.9 Cr | -1% | 9.5% | -29.9% | Stock Analytics | |
| JUST DIAL | ₹4,519.7 Cr | -2.4% | 3.5% | -44.4% | Stock Analytics | |
| AWFIS SPACE SOLUTIONS | ₹2,511.1 Cr | NA | 39.2% | -46.5% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 3.7% |
12.6% |
-5.3% |
| SENSEX | -1.3% |
4.6% |
-3.3% |
You may also like the below Video Courses